Meniere Disease
Symptoms, Doctors, Treatments, Advances & More

Learn About Meniere Disease

What is the definition of Meniere Disease?

Ménière disease is a disorder of the inner ear that affects balance and hearing. This condition is characterized by sudden episodes of extreme dizziness (vertigo), a roaring sound in the ears (tinnitus), a feeling of pressure or fullness in the ears, and fluctuations in hearing. Episodes are often associated with nausea and vomiting, and they can severely disrupt activities of daily living.

What are the causes of Meniere Disease?

The cause of Ménière disease is unknown, although it probably results from a combination of environmental and genetic factors.

How prevalent is Meniere Disease?

The prevalence of Ménière disease varies in different geographic regions and ethnic groups. It appears to be more common in people of European descent than in those with other backgrounds. In the United States, there are an estimated 615,000 people with Ménière disease, and more than 45,000 new cases are diagnosed each year.

Is Meniere Disease an inherited disorder?

Most cases of Ménière disease are sporadic, which means they occur in people with no history of the disorder in their family. A small percentage of all cases have been reported to run in families.

Who are the top Meniere Disease Local Doctors?
Elizabeth E. Redd
Distinguished in Meniere Disease
Otolaryngology
Distinguished in Meniere Disease
Otolaryngology

Bassett Medical Center

1 Atwell Road, 
Cooperstown, NY 
Languages Spoken:
English

. Dr. Redd is rated as a Distinguished provider by MediFind in the treatment of Meniere Disease. Her top areas of expertise are Infant Hearing Loss, DFNB1, Jones Syndrome, and Meniere Disease.

John P. Carey
Elite in Meniere Disease
Otolaryngology
Elite in Meniere Disease
Otolaryngology

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 6, Floor 6, 
Baltimore, MD 
Languages Spoken:
English

Neurotologist John Carey specializes in the health and diseases of the inner ear that affect both balance and hearing mechanisms. He is a national expert in superior canal dehiscence syndrome, Menière’s disease, vestibular migraine, acoustic neuromas and other causes of vertigo, and serves as chief of the Division of Otology, Neurotology and Skull Base Surgery in the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Carey earned a medical degree from Washington University School of Medicine and completed two years of training in general surgery at Virginia Mason Medical Center. This was followed by residency training in otolaryngology–head and neck surgery at University of Washington Medical Center and fellowship training in neurotology at the Johns Hopkins University School of Medicine. His research interests include superior canal dehiscence syndrome, Menière’s disease, vestibular implants, and the mechanisms of vestibular migraine. He has a particular interest in superior canal dehiscence syndrome, and, with Lloyd Minor, department director from 2003 to 2009, he helped develop the operation used to repair the superior canal. Dr. Carey has been funded by the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health. He has authored or co-authored over 150 peer-reviewed publications, 10 book chapters, and 11 reviews. Dr. Carey is rated as an Elite provider by MediFind in the treatment of Meniere Disease. His top areas of expertise are Meniere Disease, Vertigo, Acoustic Neuroma, Mastoidectomy, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Brian J. Broker
Distinguished in Meniere Disease
Otolaryngology
Distinguished in Meniere Disease
Otolaryngology

ENT And Allergy Specialists

826 Main St, Ste 201, 
Phoenixville, PA 
Languages Spoken:
English

. Dr. Broker is rated as a Distinguished provider by MediFind in the treatment of Meniere Disease. His top areas of expertise are Nasal Polyps, Sinusitis, Empyema, Septoplasty, and Balloon Sinuplasty.

What are the latest Meniere Disease Clinical Trials?
Open-Label Study of SPI-1005 for the Treatment of Meniere's Disease

Summary: Study of the safety of open-label SPI-1005 400 mg BID treatment in adults with Meniere's Disease (MD) for 6 or 12 months to support chronic or chronic intermittent use.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Study of Sleep Disorders and Their Impact on Patients With Ménière's Disease

Summary: Ménière's disease was first described by Prosper Ménière in 1861 as a balance disorder originating in the inner ear. It is diagnosed based on a characteristic clinical triad of low-frequency hearing loss, tinnitus, and vertigo attacks. The underlying cause is thought to be a pressure imbalance in the inner ear between the endolymphatic and perilymphatic sectors. The prevalence of Ménière's disease...

Who are the sources who wrote this article ?

Published Date: October 01, 2017
Published By: National Institutes of Health